Bill Ackman, who is nicknamed “Baby Buffett” because of his mastery over the stock market, has predicted that stocks will sparkle in 2021 and that we should go long
Subscribe to Blog via Email
Join 494 other subscribers
- Shalby is a multi-specialty hospital chain with expertise in joint replacementShalby is a multi-specialty hospital chain with expertise in joint replacement. It is making right strides with calibrated growth based on big ticket expansion in metros & tier I cities & asset-light franchisee expansion in tier II-VI towns. TP ₹310 (35%) Download... Shalby is a multi-specialty hospital chain with expertise in joint replacement
- DLF has strong growth prospects. Buy for target price of ₹1081 (30% upside)DLF has strong growth prospects due to strong sectoral tailwinds, record low inventory, greater preference for branded luxury, extensive launch pipeline & expansion in its annuity portfolio. Strong Balance Sheet with consistent cash flow. TP ₹1081 (+30%) Research Report... DLF has strong growth prospects. Buy for target price of ₹1081 (30% upside)
- Aditya Birla Capital has demonstrated solid performance. Buy for target price of ₹280 (37% upside)Aditya Birla Capital has demonstrated solid performance, achieving strong growth in the loan book while maintaining asset quality. Management has reiterated guidance on both growth & credit cost fronts. Lending business expected to grow at 30%. TP (+37%)... Aditya Birla Capital has demonstrated solid performance. Buy for target price of ₹280 (37% upside)
Recent Posts
- Shalby is making right strides with calibrated growth. Buy for target price of ₹310 (35% upside): ICICI Direct
- Dividend Yield Monitor 2nd November 2024 by SBI Securities
- DLF has a strong growth story given its robust launch pipeline. Buy for target price of ₹1081 (30% upside): Nuvama
- IPO: Swiggy is well recognized as a leader and a pioneer in hyperlocal commerce innovation. Subscribe to the IPO: SBI Securities
- Aditya Birla Capital Ltd has demonstrated solid performance, achieving strong growth in the loan book while maintaining asset quality. Buy for target price of ₹280 (37% upside): SBI Securities
Recent Comments